Evoke plc (LON:EVOK – Get Free Report)’s share price was down 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on EVOK shares. Berenberg Bank decreased their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th.
Read Our Latest Stock Analysis on Evoke
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, analysts predict that Evoke plc will post 12.7648305 EPS for the current year.
Insider Transactions at Evoke
In related news, insider Andrea Gisle Joosen bought 14,572 shares of the stock in a transaction on Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- Which Wall Street Analysts are the Most Accurate?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Short Nasdaq: An Easy-to-Follow Guide
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Invest in the Best Canadian Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.